Company / FCF Margin
Century Therapeutics, Inc. FCF Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-1673.8%
FY2025
5-year range
-4567.5% / -318.4%
FY2022-FY2025
Trend
+63.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -318.4% to -1673.8% over the past 2 years.
Based on SEC 10-K filings.
-1673.8% in FY2025 with a 3-year CAGR of +903.0%.
Declined from -318.4% to -1673.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +903.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 63.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1673.8% | +63.4% |
| FY2024 | -4567.5% | -1334.7% |
| FY2023 | -318.4% | +87.6% |
| FY2022 | -2576.9% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026